Overview

18F-NaF PET Imaging for Bone Scintigraphy

Status:
Completed

Trial end date:
2019-03-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare, in patients with prostate or breast cancer, the accuracy of 18F-NaF PET imaging to 99mTc whole body bone scans with single-photon emission computed tomography (SPECT).

Phase:

Phase 3

Details

Lead Sponsor:

British Columbia Cancer Agency

Collaborator:

Canadian Institutes of Health Research (CIHR)

Treatments:

Fluorides
Listerine
Sodium Fluoride
Technetium Tc 99m Medronate